GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » Price-to-Owner-Earnings

Chandra Bhagat Pharma (BOM:542934) Price-to-Owner-Earnings : 29.22 (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma Price-to-Owner-Earnings?

As of today (2024-05-15), Chandra Bhagat Pharma's share price is ₹119.80. Chandra Bhagat Pharma's Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹4.10. It's Price-to-Owner-Earnings for today is 29.22.


The historical rank and industry rank for Chandra Bhagat Pharma's Price-to-Owner-Earnings or its related term are showing as below:

BOM:542934' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.1   Med: 13.87   Max: 36.08
Current: 29.16

During the past 7 years, the highest Price-to-Owner-Earnings of Chandra Bhagat Pharma was 36.08. The lowest was 6.10. And the median was 13.87.


BOM:542934's Price-to-Owner-Earnings is ranked worse than
52.74% of 419 companies
in the Drug Manufacturers industry
Industry Median: 28.45 vs BOM:542934: 29.16

As of today (2024-05-15), Chandra Bhagat Pharma's share price is ₹119.80. Chandra Bhagat Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.55. Therefore, Chandra Bhagat Pharma's PE Ratio for today is 77.29.

As of today (2024-05-15), Chandra Bhagat Pharma's share price is ₹119.80. Chandra Bhagat Pharma's EPS without NRI for the trailing twelve months (TTM) ended in was ₹2.38. Therefore, Chandra Bhagat Pharma's PE Ratio without NRI for today is 50.25.

During the past 7 years, Chandra Bhagat Pharma's highest PE Ratio without NRI was 518.52. The lowest was 33.17. And the median was 61.20.


Chandra Bhagat Pharma Price-to-Owner-Earnings Historical Data

The historical data trend for Chandra Bhagat Pharma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma Price-to-Owner-Earnings Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - 6.10 9.35 23.69

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 9.35 - 23.69 -

Competitive Comparison of Chandra Bhagat Pharma's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chandra Bhagat Pharma's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Chandra Bhagat Pharma's Price-to-Owner-Earnings falls into.



Chandra Bhagat Pharma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Chandra Bhagat Pharma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=119.80/4.10
=29.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chandra Bhagat Pharma  (BOM:542934) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Chandra Bhagat Pharma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Chandra Bhagat Pharma (BOM:542934) Business Description

Traded in Other Exchanges
N/A
Address
Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma (BOM:542934) Headlines

No Headlines